Nerve Blocks for Knee Replacement Surgery
Trial Summary
What is the purpose of this trial?
This trial is testing if adding two specific nerve blocks to the usual pain management can better control pain and reduce the need for opioids in patients having knee replacement surgery. The study aims to see if this approach helps with pain relief and quicker recovery.
Will I have to stop taking my current medications?
The trial does not specify if you need to stop taking your current medications, but if you are currently taking anticonvulsants, you cannot participate in the trial.
What data supports the effectiveness of the treatment Genicular and Anterior Femoral Cutaneous Nerve Blocks for knee replacement surgery?
Research shows that genicular nerve blocks can provide effective pain relief and improve function in patients with knee osteoarthritis, and they have been found to reduce opioid use after knee replacement surgery. Additionally, femoral nerve blocks have been shown to significantly reduce the need for pain medication after knee surgery.12345
Is the genicular nerve block safe for humans?
Genicular nerve blocks have been used safely in various settings, such as for acute knee pain in the emergency department, where they provided effective pain relief without the need for opioids. They are considered a safe option for pain management with easily identifiable targets using ultrasound.12678
How is the treatment of Genicular and Anterior Femoral Cutaneous Nerve Blocks for knee replacement surgery different from other treatments?
This treatment is unique because it targets specific nerves (genicular and anterior femoral cutaneous) to manage pain after knee replacement surgery, potentially offering a more focused approach compared to traditional methods like femoral nerve blocks or periarticular infiltration, which may involve broader nerve coverage.1391011
Research Team
Jiabin Liu, MD, PhD
Principal Investigator
Hospital for Special Surgery, New York
Eligibility Criteria
This trial is for adults aged 18-80 undergoing knee replacement surgery without chronic opioid use, severe kidney disease, allergies to local anesthetics or study drugs, neurological deficits, or certain other health issues. They must have a BMI under 35 and not be on anticonvulsants.Inclusion Criteria
Exclusion Criteria
Trial Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants undergo total knee arthroplasty with either standard care or additional genicular and anterior femoral cutaneous nerve blocks
Immediate Post-operative Care
Participants are monitored in the post-anesthesia care unit (PACU) for pain management and readiness for discharge
Follow-up
Participants are monitored for pain levels and opioid consumption post-surgery
Treatment Details
Interventions
- Genicular and Anterior Femoral Cutaneous Nerve Blocks (Procedure)
Find a Clinic Near You
Who Is Running the Clinical Trial?
Hospital for Special Surgery, New York
Lead Sponsor
Dr. Douglas E. Padgett
Hospital for Special Surgery, New York
Chief Medical Officer since 2023
MD from Cornell University Medical College
Dr. Bryan T. Kelly
Hospital for Special Surgery, New York
Chief Executive Officer since 2023
MD, MBA